{'text': 'Amgen Presents Data From Three Trials Evaluating BLINCYTO® (blinatumomab) In Acute Lymphoblastic Leukemia At ASH 2015', 'publisher': {'href': 'https://www.prnewswire.com', 'title': 'PR Newswire'}, 'created_at': 'Mon, 07 Dec 2015 08:00:00 GMT', 'description': 'Amgen Presents Data From Three Trials Evaluating BLINCYTO® (blinatumomab) In Acute Lymphoblastic Leukemia At ASH 2015  PR Newswire', 'url': 'https://news.google.com/rss/articles/CBMi_wFBVV95cUxPQ2ltWDRXRll2cWg5SzdhY193TjNlellVczItbnF5VTJCUXk2VU5McHdyTWczZmNYQjdadmpCZjJQWkFjMlZOWUxvWkFjbDdtSXJqTTJRd2JuS182eXZkeUFIZEVSSFJFYldHT2ZGOTc5dUlXeUdDNjY3U2t2aS1FdVhDTnBpVnVENjJON0h2SVFBZnk5ajJleEdVTFJrcHpQdlRlbXk4R1NMak50TUFBaG5HOWhqS18ySTl6UzFRR3ZCQ2ZsMTNuRVVTSlkyaDdJdGVnVlBJTlF1ZUpRYk14UzUyVmRZQzhoQjNwb2ROLXpxeUVEbjloMnRGdUNUcVk?oc=5&hl=en-US&gl=US&ceid=US:en'}
